PDGFRB and Alzheimer disease: In the whole cohort, the PCA analysis yielded a ‘core AD’ component (CSF AD biomarkers and synaptic markers, 48% of the variance) while CSF PDGFRβ segregated with neuroinflammation, axonal, and albumin markers in Component 2 (16% of the variance).